[1] National Medical Products Administration. Administrative Measures on Reporting and Monitoring of ADR (Order No. 81 of the Ministry of Health)[EB/OL]. (2011-05-04) [2020-05-17]. http://www.nmpa.gov.cn/WS04/CL2174/300642.html. [2] WANG RQ,HUO YF,XIE YJ,et al.Retrospective analysis of 530 cases of new/severe pediatric ADR in Shandong Province during 2016-2017[J]. China Pharmacy(中国药房),2019,30(1):115-119. [3] National Medical Products Administration. Notice on Issuing the Annual Report of National Adverse Drug Reaction Monitoring (2019)[EB/OL]. (2020-04-10) [2020-05-17]. http://www.cdr-adr.org.cn/tzgg_home/202004/t20200410_47300.html. [4] China Food and Drug Administration. Technical Guidelines for Pharmacokinetic Studies in Pediatric Population[EB/OL]. (2014-07-11) [2020-05-17]. http://www.sda.gov.cn/WS01/CL0844/103095.html. [5] ZHONG NS.Guiding Principles of Clinical Use of Antibiotics(2015)(抗菌药物临床应用指导原则(2015年版))[M]. Beijing:People's Medical Publishing House, 2015. [6] Uppsala Monitoring Centre. What is WHO-ART[EB/OL]. (2019-04-25)[2019-04-25]. https://www.who-umc.org/vigibase/services/learn-more-about-who-art/. [7] LIANG H, WEI FH, ZHONG LQ.Analysis of 233 cases of adr induced by antibacterials in our hospital[J].China Pharmacy(中国药房), 2016, 27(5):632-634. [8] WANG YP, ZHONG W.Analysis on 687 reports of adverse drug reaction of children caused by antibacterial agents[J]. Anti Infect Pharm(抗感染药学), 2018, 15(10):1755-1757. [9] ZHENG C.Analysis of Influencing factors of adverse reaction induced by antibacterial drugs in 222 children in a hospital[J]. China Licensed Pharmacist(中国执业药师), 2016, 13(11): 44-47. [10] ZHOU LF, JIANG Y, ZHONG W, et al.Analysis of 332 cases of adverse drug reactions of children in our hospital[J]. Northwest Pharmaceutical Journal(西北药学杂志), 2019, 34(2): 272-275. [11] Editorial board of Chinese National Formulary. Chinese National Formulary(Chemicals and Biological Products for Children)(中国国家处方集(化学药品与生物制品卷•儿童版))[M]. Beijing:People's Military Medical Press, 2013. [12] ZHONG W, MAO CM, WANG M.Retrospective analysis of 562 cases of pediatric adverse drug reactions[J]. Journal of Pediatric Pharmacy(儿科药学杂志), 2018, 24(10): 39-42. [13] MA J, MAO CM.Analysis of 408 pediatric cases with adverse drug Reaction[J]. Anhui Medical and Pharmaceutical Journal(安徽医药),2017, 21(6): 1150-1153. [14] ZHOU L, SHI YP, HOU HL, et al.Adverse drug reactions in 108 children[J]. Journal of Pediatric Pharmacy(儿科药学杂志),2019, 25(4): 51-53. [15] HIAMG CL, GUO DH, ZHU M, et al.Analysis on 9819 cases of ADR/ADE associated with quinolones in military hospitals[J]. Chinese Journal of Drug Application and Monitoring(中国药物应用与监测), 2017, 14(5): 293-296. [16] ZHOU P, ZHU HY, CUI L.Investigation and analysis of adr reported and causes of missing reports by medical staff in a third grade class a hospital[J]. China Pharmacy(中国药房),2017, 28(36): 5056-5059. [17] ZHANG Q.Retrospective analysis of 147 cases of adverse drug reactions[J]. Anhui Medical and Pharmaceutical Journal(安徽医药), 2019, 23(4): 846-848. [18] WANG Y, XU Z.Analysis of 176 Pediatric ADR reports in our hospital[J]. China Pharmacy(中国药房), 2016, 27(26): 3649-3651. [19] MENG XQ, ZHAO N, ZUO J, et al.Analysis of adverse drug reactions in reports of children and maternal in a hospital[J]. Anhui Medical and Pharmaceutical Journal(安徽医药),2017,21(10): 1938-1942. |